Cargando…
Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial
BACKGROUND: Current surgical and ablative treatment options for prostate cancer (PCa) may result in a high incidence of (temporary) incontinence, erectile dysfunction and/or bowel damage. These side effects are due to procedure related effects on adjacent structures including blood vessels, bowel, u...
Autores principales: | Scheltema, Matthijs J. V., van den Bos, Willemien, de Bruin, Daniel M., Wijkstra, Hessel, Laguna, M. Pilar, de Reijke, Theo M., de la Rosette, Jean JMCH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858903/ https://www.ncbi.nlm.nih.gov/pubmed/27150293 http://dx.doi.org/10.1186/s12885-016-2332-z |
Ejemplares similares
-
Irreversible electroporation: state of the art
por: Wagstaff, Peter GK, et al.
Publicado: (2016) -
The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol
por: Wagstaff, Peter GK, et al.
Publicado: (2015) -
Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b)
por: Buijs, Mara, et al.
Publicado: (2017) -
Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences
por: Scheltema, Matthijs J., et al.
Publicado: (2019) -
The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients
por: van den Bos, W., et al.
Publicado: (2015)